18 and older, any sex, with Chemotherapy-induced Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change of Neuropathy in Actively Treated Multiple Myeloma Subjects Diagnosed With Chemotherapy-induced Peripheral Neuropathy Who Received Acupuncture vs Standard of Care Management.Primary· Approximately 10 weeks, from baseline measure to 10 week (+/- 1 week) measure.
Neuropathy will be subject reported using an 11-point scale from 0-no neuropathy to 10-worst possible neuropathy. The outcome will be measured as a binary variable indicating whether or not a subject experienced at least a 2-point improvement in neuropathy between the baseline score and the score obtained at Week 10 +/- 1 week.
Group
Value
95% CI
Acupuncture
6
Standard of Care
0
Acupuncture
1
Standard of Care
1
Specific Features of Chemotherapy-Induced Peripheral Neuropathy From FACT-GOG-NTXSecondary· 10 weeks
Specific features of CIPN assessed through the subscale from FACT-GOG-NTX will be determined for each subject as a composite measure, which is calculated as the sum of the responses to the subscale questions. For subjects who complete all 12 subscale questions, the composite score will range from 0 to 48. Higher scores mean worse outcome
Group
Value
95% CI
Acupuncture
14.0
5.0 – 27.0
Standard of Care
23.0
23.0 – 23.0
Nausea - FACT-GOG-NTXSecondary· approx. 10 weeks
Nausea will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GP2 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I have nausea.'
Group
Value
95% CI
Acupuncture
7
Standard of Care
1
Acupuncture
0
Standard of Care
0
Acupuncture
0
Standard of Care
0
Acupuncture
0
Standard of Care
0
Sadness- FACT-GOG-NTXSecondary· approx. 10 weeks
Sadness will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GE1 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I feel sad'.
Nervousness will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GE4 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I feel nervous.'
Sleep quality will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GF5 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I am sleeping well.'
Group
Value
95% CI
Acupuncture
0
Standard of Care
0
Acupuncture
0
Standard of Care
0
Acupuncture
4
Standard of Care
0
Acupuncture
2
Standard of Care
0
Lack of Energy- FACT-GOG-NTXSecondary· approx. 10 weeks
Lack of energy will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GP1 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I have a lack of energy.'
Group
Value
95% CI
Acupuncture
2
Standard of Care
0
Acupuncture
3
Standard of Care
0
Acupuncture
2
Standard of Care
1
Acupuncture
0
Standard of Care
0
Pain- FACT-GOG-NTXSecondary· approx. 10 weeks
Pain will be determined for each subject as 5 level ordinal variable from 0 = not at all to 4 = very much through question GP4 on the FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I have pain.'
Group
Value
95% CI
Acupuncture
1
Standard of Care
0
Acupuncture
3
Standard of Care
0
Acupuncture
2
Standard of Care
0
Acupuncture
1
Standard of Care
1
ConstipationSecondary· approx. 10 weeks
Constipation will be determined for each subject as a 5-level ordinal variable from 0 = not at all to 4 = very much through additional question amended to FACT-GOG-NTX subject-reported assessment. The item is to rate the statement 'I have constipation.'
Group
Value
95% CI
Acupuncture
0
Standard of Care
0
Acupuncture
5
Standard of Care
0
Acupuncture
1
Standard of Care
1
Acupuncture
1
Standard of Care
0
DizzinessSecondary· approx. 10 weeks
Dizziness will be determined for each subject as a 5- level ordinal variable from 0 = not at all to 4 = very much through additional question amended to FACT-GOG-NTX subject-reported assessment. This item is to rate the statement 'I have dizziness'.
Group
Value
95% CI
Acupuncture
1
Standard of Care
0
Acupuncture
3
Standard of Care
1
Acupuncture
2
Standard of Care
0
Acupuncture
1
Standard of Care
0
Dry MouthSecondary· approx. 10 weeks
Dry mouth will be determined for each subject as a 5- level ordinal variable from 0 = not at all to 4 = very much through additional question amended to FACT-GOG-NTX subject-reported assessment. This item is to rate the statement 'I have dry mouth.'
Group
Value
95% CI
Acupuncture
1
Standard of Care
0
Acupuncture
5
Standard of Care
0
Acupuncture
0
Standard of Care
1
Acupuncture
1
Standard of Care
0
General Health - CDC-HRQOLSecondary· approx. 10 weeks
General Health assessed through CDC-HRQOL Question 1 will be calculated for each subject as a 5- level ordinal variable from Poor to Excellent.
Group
Value
95% CI
Acupuncture
0
Standard of Care
0
Acupuncture
1
Standard of Care
0
Acupuncture
4
Standard of Care
1
Acupuncture
2
Standard of Care
0
Sponsor's own description
This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07522567 — Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures
· NA
· not yet recruiting
NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss
· NA
· recruiting
NCT07522710 — Clinical Study on Intensive Multi-acupuncture in the Treatment of Neck and Shoulder Myofascial Pain Syndrome
· NA
· not yet recruiting
NCT07505927 — Acupuncture for Postoperative Gastric Emptying Delay
· NA
· not yet recruiting
NCT07410793 — Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
· Phase 2
· recruiting
Other recruiting trials for Chemotherapy-induced Peripheral Neuropathy
Currently open trials in the same condition.
NCT07177820 — VGAIT for Chemotherapy-induced Peripheral Neuropathy
· NA
· recruiting
NCT07072468 — Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
· Phase 2
· recruiting
NCT06389721 — Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
· recruiting
NCT06405542 — Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN)
· Phase 1
· active not recruiting
NCT06162403 — Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longi
· NA
· recruiting
Other Wake Forest University Health Sciences trials
Trials by the same sponsor.
NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
· NA
· not yet recruiting
NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
· NA
· not yet recruiting
NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
· NA
· recruiting
NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
· NA
· recruiting
NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04770402.